GoHealth delays quarterly filing amid restructuring talks

GoHealth ( (GOCO) ) has released a notification of late filing.

GoHealth, Inc. has filed a Form 12b-25 to notify investors of a delayed Form 10-Q (Quarter Report) for the quarter ended March 31, 2026. The company’s late filing relates specifically to this Form 10-Q (Quarter Report) for its latest reported financial period.

Management cites ongoing negotiations with lenders and other stakeholders over strategic options to fix its capital structure and liquidity as the key reason for the delay. These talks could result in a change of control or other restructuring, adding uncertainty and complexity to the required disclosures.

Because of this uncertainty, GoHealth needed extra time to gather and analyze information and to finalize the narrative and risk-related sections in the Form 10-Q (Quarter Report). The company states that filing on time would have required unreasonable effort or expense under these circumstances.

GoHealth indicates it will file, and in fact is filing, the Form 10-Q (Quarter Report) substantially concurrently with this late filing notice dated May 18, 2026. This timing is within the SEC’s five-day grace period for a quarterly report when a Form 12b-25 is properly submitted.

The company warns that it will disclose in the Form 10-Q (Quarter Report) that there is substantial doubt about its ability to continue as a going concern. For investors, this going-concern warning signals serious pressure on GoHealth’s liquidity and its capacity to meet obligations without a successful restructuring.

GoHealth also expects a significant change in operating results versus the same quarter of 2025, driven by a decline in revenues for the three months ended March 31, 2026. Detailed figures will appear in the Form 10-Q (Quarter Report), and the company has not provided a full quantitative outlook in this notice.

The filing emphasizes that discussions about strategic alternatives, potential change of control, restructuring options, and liquidity outcomes are all forward-looking statements. Management highlights that actual results may differ materially due to numerous risks, including deal timing, access to capital, and the impact of any transaction on stakeholders.

GoHealth affirms that all other required periodic reports over the past 12 months have been filed on time, suggesting this delay is an isolated event tied to current restructuring talks. The notification is signed by Brendan Shanahan, Chief Financial Officer, underscoring the company’s ongoing effort to remain compliant while it evaluates its financial future.

The most recent analyst rating on (GOCO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on GoHealth stock, see the GOCO Stock Forecast page.

Spark’s Take on GOCO Stock

According to Spark, TipRanks’ AI Analyst, GOCO is a Neutral.

The score is held down primarily by deteriorating financial performance (sharp revenue decline, large losses, and ongoing cash burn). Technicals add further pressure due to a clear downtrend and negative momentum indicators. Valuation provides limited offset given negative earnings, and the Nasdaq noncompliance/delisting risk is an additional material overhang.

To see Spark’s full report on GOCO stock, click here.

More about GoHealth

Average Trading Volume: 75,126

Technical Sentiment Signal: Sell

Current Market Cap: $24.66M

For detailed information about GOCO stock, go to TipRanks’ Stock Analysis page.